Resultados de procura - Lyubomir T. Vassilev

Limitar resultados
  1. 1
    Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics

    Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics por Lyubomir T. Vassilev

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Cell Cycle Synchronization at the G<sub>2</sub>/M Phase Border by Reversible Inhibition of CDK1

    Cell Cycle Synchronization at the G<sub>2</sub>/M Phase Border by Reversible Inhibition of CDK1 por Lyubomir T. Vassilev

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Targeting the p53–MDM2 interaction to treat cancer

    Targeting the p53–MDM2 interaction to treat cancer por Christian Klein, Lyubomir T. Vassilev

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells.

    An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. por Lyubomir T. Vassilev, Edward M. Johnson

    Publicado 1990
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Mapping initiation sites of DNA replication<i>in vivo</i>using polymerase chain reaction amplification of nascent strand segments

    Mapping initiation sites of DNA replication<i>in vivo</i>using polymerase chain reaction amplification of nascent strand segments por Lyubomir T. Vassilev, Edward M. Johnson

    Publicado 1989
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation

    p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation por Mingxuan Xia, Dejan Knezevic, Lyubomir T. Vassilev

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Mapping an origin of DNA replication at a single-copy locus in exponentially proliferating mammalian cells.

    Mapping an origin of DNA replication at a single-copy locus in exponentially proliferating mammalian cells. por Lyubomir T. Vassilev, William C. Burhans, Melvin L. DePamphilis

    Publicado 1990
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death

    Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death por Li-Ya Chiu, Qing Sun, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity

    Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity por Zakir Ullah, Matthew J. Kohn, Rieko Yagi, Lyubomir T. Vassilev, Melvin L. DePamphilis

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin

    Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin por Alejo Efeyan, Ana Ortega-Molina, Susana Velasco-Miguel, Daniel Herranz, Lyubomir T. Vassilev, Manuel Serrano

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation.

    Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation. por William C. Burhans, Lyubomir T. Vassilev, Jiarui Wu, José M. Sogo, Ferez S. Nallaseth, Melvin L. DePamphilis

    Publicado 1991
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1

    Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1 por Lyubomir T. Vassilev, Christian Tovar, Shaoqing Chen, Dejan Knezevic, Xiaolan Zhao, Hongmao Sun, David Heimbrook, Li Chen

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

    MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines por Hege O. Ohnstad, Erik B. Paulsen, Paul Noordhuis, Marianne Berg, Ragnhild A. Lothe, Lyubomir T. Vassilev, Ola Myklebost

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814

    Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814 por Qing Sun, Yige Guo, Xiaohong Liu, Frank Czauderna, Michael I. Carr, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5

    Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5 por Bing Z. Carter, Duncan H. Mak, Wendy Schober, Martin Dietrich, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML

    Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML por Bing Z. Carter, Duncan H. Mak, Wendy Schober, Erich Koller, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis

    Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis por Thelma Thompson, Christian Tovar, Hong Yang, Daisy Carvajal, Binh Thanh Vu, Qunli Xu, Geoffrey M. Wahl, David Heimbrook, Lyubomir T. Vassilev

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors

    Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors por Mikhail V. Blagosklonny, Shana Y. Trostel, Ganesh Kayastha, Zoya N. Demidenko, Lyubomir T. Vassilev, Larisa Y. Romanova, Susan E. Bates, Tito Fojo

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies

    A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies por Astrid Zimmermann, Frank T. Zenke, Li-Ya Chiu, Heike Dahmen, Ulrich Pehl, Thomas Fuchß, Thomas Grombacher, Beatrix Blume, Lyubomir T. Vassilev, Andree Blaukat

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models

    Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models por Frank T. Zenke, Astrid Zimmermann, Christian Sirrenberg, Heike Dahmen, Vladimir Kirkin, Ulrich Pehl, Thomas Grombacher, Claudia Wilm, Thomas Fuchß, Christiane Amendt, Lyubomir T. Vassilev, Andree Blaukat

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: